Silva Pharmaceuticals Limited (DSE: SILVAPHL)

Market Cap	1.42B
Revenue (ttm)	611.62M
Net Income (ttm)	-30.91M
Shares Out	136.50M
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.96%)
Ex-Dividend Date	Dec 2, 2024

Volume	213,037
Open	10.40
Previous Close	10.40
Day's Range	10.30 - 10.60
52-Week Range	8.60 - 21.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh. The company offers drugs for antibiotics, antifungals, analgesics, anti-diabetics, anti-pyretics, anti-inflammatory, anti-ulcerants, respiratory, cardiovascular, central nervous system, dermatology, gastrointenstinal, antiemetic and anti-spasmodic, antibacterial, allergies, cough, and cold, as well as natural sweetner, vitamins and minerals. It also provides medicine and vaccine for farmers and fisheries; agricultural chemicals and publi...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 587
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILVAPHL

Financial Performance

In 2023, Silva Pharmaceuticals's revenue was 716.87 million, a decrease of -7.94% compared to the previous year's 778.67 million. Earnings were 33.08 million, a decrease of -67.65%.